Glucagon-like peptide-1 (GLP-1) compounds have emerged as a compelling therapeutic strategy for managing metabolic conditions. These naturally occurring molecules are secreted by the gut in response to meal intake, stimulating insulin secretion and suppressing glucagon secretion. GLP-1 peptides possess promising therapeutic results in treating type